Farzin Khosrow‐Khavar

Author

Also Known As

F Khosrow-Khavar, F Khosrow‐Khavar, F. Khosrow-Khavar, F. Khosrow‐Khavar, Farzin Khosrow-Khavar, Farzin Khosrow‐Khavar, Khosrow-Khavar, Farzin

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

McGill University Jewish General Hospital McGill University Health Centre Brigham and Women's Hospital Université de Montréal

About

Farzin Khosrow‐Khavar is an author at McGill University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	103
2	Health Sciences	1	1	21
3	Natural Sciences	1	1	39
4	Public Health	1	1	51
5	Cell Biology	1	1	39

Farzin Khosrow‐Khavar

Publications

660

Citations

H-Index

Page 1

	Year	Citations
Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study Farzin Khosrow‐Khavar, Seoyoung C. Kim, Hemin Lee, Annals of the Rheumatic Diseases	2022	153
Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer Farzin Khosrow‐Khavar, Kristian B. Filion, Nathaniel Bouganim, Circulation	2020	142
Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR‐RA) Study Farzin Khosrow‐Khavar, Rishi Desai, Hemin Lee, Arthritis & Rheumatology	2022	74
Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer Farzin Khosrow‐Khavar, Soham Rej, Hui Yin, Journal of Clinical Oncology	2017	68
MORPHEUS Phase II–III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results Aurélie Garant, Carol‐Ann Vasilevsky, Marylise Boutros, Cancers	2022	52
Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation Center Rishi Desai, Shirley Wang, Sushama Kattinakere Sreedhara, BMJ Evidence-based InterventionAdverse Drug ReactionClinical TrialsRandomized Controlled TrialDrug Monitoring	2024	51
The Yeast Ubr1 Ubiquitin Ligase Participates in a Prominent Pathway That Targets Cytosolic Thermosensitive Mutants for Degradation Farzin Khosrow‐Khavar, Nancy N. Fang, Alex H. M. Ng, G3 Genes Genomes Genetics ProteasomeMolecular BiologyMolecular GeneticsRestrictive TemperatureProtein Folding	2012	39
Comparing local control and distant metastasis in NSCLC patients between CyberKnife and conventional SBRT André Diamant, Veng Jean Heng, Avishek Chatterjee, Radiotherapy and Oncology Local ControlDistant MetastasisConventional SbrtOncologyRadiation Oncology	2020	21
Cardiotoxicity of Use of Sequential Aromatase Inhibitors in Women With Breast Cancer Farzin Khosrow‐Khavar, Nathaniel Bouganim, Kristian B. Filion, American Journal of Epidemiology	2020	16
Phase II trial of perioperative chemotherapy + avelumab in locally advanced gastroesophageal adenocarcinoma: Preliminary results. Thierry Alcindor, Touhid Opu, Arielle Elkrief, Journal of Clinical Oncology Surgical OncologyEsophageal CancerCancer ManagementGastroenterologyPathology	2021	13

Page 1